• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

社区药房围绝经期女性心血管风险筛查试点项目：MENOVASC项目

[Pilot programme for screening perimenopausal women for cardiovascular risk from community pharmacy: MENOVASC Project].

作者信息

Palazón-Palazón Andrea, Sánchez-Martínez Diego-Pablo

机构信息

Estudiante Grado en Farmacia de la Universidad de Murcia España.

Farmacéutico y profesor asociado de la Universidad de Murcia Universidad de Murcia España.

出版信息

Farm Comunitarios. 2023 Apr 14;15(3):17-24. doi: 10.33620/FC.2173-9218.(2023).17. eCollection 2023 Jul 15.

DOI:10.33620/FC.2173-9218.(2023).17
PMID:39157698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11328070/
Abstract

INTRODUCTION

Cardiovascular diseases have been the leading cause of death in the world for more than 20 years. They are generally unusual in premenopausal women due to the cardiovascular protection of endogenous estrogens, so the cardiovascular risk in these has traditionally been underestimated.

OBJECTIVES

Establish a protocol for vascular risk screening in perimenopausal women from the community pharmacy.

MATERIAL AND METHODS

Descriptive study from an opportunistic sample in a community pharmacy of women between 45 and 55 years old. Participants were cited at the pharmacy and their cholesterol and blood pressure levels, weight, and height were taken. Information was collected on women's general and specific cardiovascular risk factors, medication they were taking and smoking. These data were used to estimate cardiovascular risk using SCORE tables.

RESULTS

18 forms were collected, with the average age of the applicants being 49 (SD 3) years old. 38.9% (CI95%: 17.3 a 64.3) had high blood pressure and 44.4% (CI95%: 21.5 a 69.2) had cholesterol levels equal to or higher than 190 mg/ml. 100% had some traditional or specific risk factor for women.

CONCLUSIONS

The usefulness of vascular risk screening in perimenopausal women is confirmed. All this places value on the intervention of the community pharmacist in the detection and management of cardiovascular risk factors.

摘要

引言

二十多年来，心血管疾病一直是全球主要的死亡原因。由于内源性雌激素对心血管的保护作用，心血管疾病在绝经前女性中通常并不常见，因此这些女性的心血管风险传统上一直被低估。

目的

制定一项针对社区药房围绝经期女性进行血管风险筛查的方案。

材料与方法

对一家社区药房中45至55岁女性的机会性样本进行描述性研究。参与者在药房被邀请，并测量其胆固醇和血压水平、体重和身高。收集有关女性一般和特定心血管危险因素、正在服用的药物以及吸烟情况的信息。这些数据用于使用SCORE表估计心血管风险。

结果

共收集到18份表格，申请者的平均年龄为49（标准差3）岁。38.9%（95%置信区间：17.3至64.3）患有高血压，44.4%（95%置信区间：21.5至69.2）的胆固醇水平等于或高于190毫克/毫升。100%的人有一些女性传统或特定的危险因素。

结论

证实了围绝经期女性进行血管风险筛查的有用性。所有这些都凸显了社区药剂师在检测和管理心血管危险因素方面干预措施的价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8087/11328070/fa26c8e83465/FC15-03-03_gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8087/11328070/63fe400df3d2/FC15-03-03_gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8087/11328070/fa26c8e83465/FC15-03-03_gf02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8087/11328070/63fe400df3d2/FC15-03-03_gf01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8087/11328070/fa26c8e83465/FC15-03-03_gf02.jpg

相似文献

1
[Pilot programme for screening perimenopausal women for cardiovascular risk from community pharmacy: MENOVASC Project].社区药房围绝经期女性心血管风险筛查试点项目：MENOVASC项目
Farm Comunitarios. 2023 Apr 14;15(3):17-24. doi: 10.33620/FC.2173-9218.(2023).17. eCollection 2023 Jul 15.
2
Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women.围绝经期对中年健康女性心血管危险因素及症状的影响。
Arch Intern Med. 1994 Oct 24;154(20):2349-55.
3
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区，服用抗叶酸抗疟药物的人群中，叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Screening Services in a Community Pharmacy in Poznan (Poland) to Increase Early Detection of Hypertension.波兰波兹南一家社区药房的筛查服务，以提高高血压的早期检测率。
J Clin Med. 2020 Aug 8;9(8):2572. doi: 10.3390/jcm9082572.
6
Long term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗。
Cochrane Database Syst Rev. 2012 Jul 11(7):CD004143. doi: 10.1002/14651858.CD004143.pub4.
7
Association of sedentary time and physical fitness with ideal cardiovascular health in perimenopausal women: The FLAMENCO project.绝经后女性久坐时间和身体适应性与理想心血管健康的关系：FLAMENCO 项目。
Maturitas. 2019 Feb;120:53-60. doi: 10.1016/j.maturitas.2018.11.015. Epub 2018 Nov 23.
8
The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.药师干预对心血管风险的影响：多中心随机对照 RxEACH 试验。
J Am Coll Cardiol. 2016 Jun 21;67(24):2846-54. doi: 10.1016/j.jacc.2016.03.528. Epub 2016 Apr 4.
9
Physical, psychological, and menopause-related symptoms and minor psychiatric disorders in a community-based sample of Brazilian premenopausal, perimenopausal, and postmenopausal women.巴西绝经前、围绝经期和绝经后妇女社区样本中的身体、心理和与绝经相关的症状以及轻度精神障碍。
Menopause. 2012 Mar;19(3):355-60. doi: 10.1097/gme.0b013e31822ba026.
10
Diabetes and cardiovascular disease risk screening model in community pharmacies in a developing primary healthcare system: a feasibility study.发展中国家基层医疗体系中社区药房的糖尿病和心血管疾病风险筛查模型：一项可行性研究
BMJ Open. 2019 Nov 10;9(11):e031246. doi: 10.1136/bmjopen-2019-031246.

本文引用的文献

1
The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk.在评估女性心血管风险时使用性别特异性因素。
Circulation. 2020 Feb 18;141(7):592-599. doi: 10.1161/CIRCULATIONAHA.119.043429. Epub 2020 Feb 17.
2
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南：通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
3
The Effectiveness of Pharmacist Interventions on Cardiovascular Risk: The Multicenter Randomized Controlled RxEACH Trial.
药师干预对心血管风险的影响：多中心随机对照 RxEACH 试验。
J Am Coll Cardiol. 2016 Jun 21;67(24):2846-54. doi: 10.1016/j.jacc.2016.03.528. Epub 2016 Apr 4.
4
Sex differences in cardiovascular risk factors and disease prevention.心血管危险因素与疾病预防中的性别差异。
Atherosclerosis. 2015 Jul;241(1):211-8. doi: 10.1016/j.atherosclerosis.2015.01.027. Epub 2015 Jan 28.
5
[Cardiovascular risk factors and Primary Care: evaluation and intervention].[心血管危险因素与初级保健：评估与干预]
Aten Primaria. 2011 Dec;43(12):668-77. doi: 10.1016/j.aprim.2011.10.002. Epub 2011 Nov 17.
6
Screening for pre-hypertension and elevated cardiovascular risk factors in a Thai community pharmacy.泰国社区药房中高血压前期及心血管危险因素升高的筛查。
Pharm World Sci. 2010 Jun;32(3):329-33. doi: 10.1007/s11096-010-9373-1. Epub 2010 Feb 26.
7
Point-of-care testing of cholesterol and triglycerides for epidemiologic studies: evaluation of the multicare-in system.
Transl Res. 2009 Feb;153(2):71-6. doi: 10.1016/j.trsl.2008.11.010. Epub 2008 Dec 16.
8
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).欧洲临床实践心血管疾病预防指南：执行摘要：欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第四次报告（由九个学会的代表及特邀专家组成）
Eur Heart J. 2007 Oct;28(19):2375-414. doi: 10.1093/eurheartj/ehm316. Epub 2007 Aug 28.
9
Application of national screening criteria for blood pressure and cholesterol to perimenopausal women: prevalence of hypertension and hypercholesterolemia in the Study of Women's Health Across the Nation.
Prev Cardiol. 2006 Summer;9(3):150-9. doi: 10.1111/j.1520-037x.2006.04757.x.
10
Concurrent and predictive validity of a self-reported measure of medication adherence.一种自我报告的药物依从性测量方法的同时效度和预测效度。
Med Care. 1986 Jan;24(1):67-74. doi: 10.1097/00005650-198601000-00007.